The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

The biotechnology industry has long been characterized by astronomical development costs and lengthy timelines that can stretch into decades. Traditional drug development programs routinely require ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

A surge in deals and financings had the industry abuzz heading into this year’s J.P Morgan Healthcare Conference. But some ...

Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies are expected to go public amid a renewed ...

Milwaukee Area Technical College unveiled a 2,000 square foot biotech classroom and lab at its downtown campus to train students starting in spring 2026.